| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Hospital & Healthcare Services
|
Compare with Industry peers |
| Website | http://www.madhavbaug.org | |
| Market Cap | 210.85 Cr. | |
| Enterprise Value(EV) | 214.86 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 4.60 | Trailing Twelve Months Ending 2023-03 |
| Price-Earning Ratio (PE) | 43.63 | Trailing Twelve Months Ending 2023-03 |
| Industry PE | 67.02 | Trailing Twelve Months Ending 2023-03 |
| Book Value / Share | 38.48 | Trailing Twelve Months Ending 2023-03 |
| Price to Book Value | 5.21 | Calculated using Price: 200.55 |
| Dividend Yield | 0.12 | Period Ending 2023-03 |
| No. of Shares Subscribed | 1.05 Cr. | 10,513,450 Shares |
| FaceValue | 10 | |
| About Vaidya Sane Ayurved Laboratories Ltd. | ||
| The company is a medical service institution engaged in the treatment of chronic ailments like cardiac disease, diabetes, hypertension, and obesity by combining modern technology with the traditional Ayurveda practices. | ||
| 1 Day |
|
-2.65% |
| 1 Week |
|
+1.80% |
| 1 Month |
|
+2.32% |
| 3 Month |
|
-6.39% |
| 6 Month |
|
-29.63% |
| 1 Year |
|
-16.44% |
| 2 Year |
|
-0.72% |
| 5 Year |
|
|
| 10 Year |
|
| 1 years | 2023-03 | |
| Return on Equity (%) | 11.95 | |
| Return on Capital Employed (%) | 17.96 | |
| Return on Assets (%) | 8.82 |
| Particulars | 2 years | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 40 | 41 | |
| Non Curr. Liab. | 1 | 2 | |
| Curr. Liab. | 13 | 12 | |
| Minority Int. | |||
| Equity & Liab. | 55 | 69 | |
| Non Curr. Assets | 27 | 34 | |
| Curr. Assets | 28 | 35 | |
| Misc. Exp. not W/O | |||
| Total Assets | 55 | 69 |
| Particulars | 1 years | 2023-03 Rs. Cr. |
| Net Sales | 99 | |
| Other Income | 1 | |
| Total Income | 101 | |
| Total Expenditure | -91 | |
| PBIDT | 10 | |
| Interest | -1 | |
| Depreciation | -3 | |
| Taxation | -2 | |
| Exceptional Items | ||
| PAT | 5 | |
| Minority Interest | ||
| Share Associate | ||
| Other Related Items | ||
| Consolidated Net Profit | 5 | |
| Adjusted EPS | 5 |
| Particulars | 1 years | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | 0 | |
| Cash Fr. Inv. | 1 | |
| Cash Fr. Finan. | -1 | |
| Net Change | -1 | |
| Cash & Cash Eqvt | 2 |
|
Mon, 15 Apr 2024
Press Release Vaidya Sane Ayurved Laboratories Limited has informed the Exchange regarding a press release dated April 15, 2024, titled Appointment of AVP Marketing and Sales, Mr. Shantanu Joshi. |
|
Wed, 10 Apr 2024
Disclosure under SEBI Takeover Regulations Rohit Madhav Sane and Rekha Jitesh Paralkar has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |
|
Sat, 06 Apr 2024
Updates Vaidya Sane Ayurved Laboratories Limited has informed the Exchange regarding 'Compliance Certificate_ 74 (5) for quarter ended 31st March 2024'. |
| Fri, 26 Apr 2024 |
Opening at High
|
Closing Below Previous Low
|
High Decrease in 6 Months
|
CCI Bearish
|
William %R Trending Down
|
